Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
Dmitry S. Karpov, Anastasiia O. Sosnovtseva, S. V. Pylina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17320-17320
Open Access | Times Cited: 11

Showing 11 citing articles:

Research on the application of CRISPR technology in the treatment of type 1 diabetes (T1D)
Mingyi Chen, Juntong Liu, L Zhang
Theoretical and Natural Science (2025) Vol. 82, Iss. 1, pp. 19-26
Closed Access
Islet Cell Replacement and Regeneration for Type 1 Diabetes: Current Developments and Future Prospects
Arthur Rech Tondin, Giacomo Lanzoni
BioDrugs (2025)
Open Access
A Multidisciplinary Approach of Type 1 Diabetes: The Intersection of Technology, Immunotherapy, and Personalized Medicine
Denisa Batîr-Marin, Claudia Simona Ștefan, Monica Boev, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2144-2144
Open Access
CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans
Dmitry S. Karpov
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5292-5292
Open Access | Times Cited: 4
Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy
Ahmad Bairqdar, Polina E. Karitskaya, Г. А. Степанов
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13321-13321
Open Access | Times Cited: 2
Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
Sarkar Sardar Azeez, Rahin Shareef Hamad, Bahra Kakamin Hamad, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 2
CRISPR/Cas9-mediated genome editing: from basic research to gene therapy
Rajeev Goel
International Journal of Research in Medical Sciences (2024) Vol. 12, Iss. 6, pp. 2200-2211
Open Access | Times Cited: 1
Flash glucose monitoring in diabetes
Annel Lameijer
(2024)
Open Access
Advances in CRISPR/Cas systems-based cell and gene therapy
Arpita Poddar, Farah Ahmady, Prashanth Prithviraj, et al.
Progress in molecular biology and translational science (2024), pp. 161-183
Closed Access
Deciphering the Genetic Landscape: Exploring the Relationship Between HLA-DQA1, HLA-DQB1, and HLA-DRB1 Genes in Diabetes Mellitus
Kuldeep Singh, Jeetendra Kumar Gupta, Dilip Kumar Chanchal, et al.
Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine (2024) Vol. 21, Iss. 3, pp. 125-135
Closed Access
Human Stem Cell Therapy for the Cure of Type 1 Diabetes Mellitus (T1D): A Hurdle Course between Lights and Shadows
Riccardo Calafiore, Giovanni Luca, Francesco Gaggia, et al.
Endocrines (2024) Vol. 5, Iss. 4, pp. 465-477
Open Access
Page 1

Scroll to top